International Drug Development (IDD)

International Drug Development (IDD) is a Paris-based pharmaceutical and regulatory consulting firm that supports pharmaceutical and biotech companies throughout the entire product lifecycle. Their services span from initial drug development and regulatory strategy (CTA/IND submissions) to post-approval lifecycle management, compliance, and commercial operations. In addition to consulting, the group has evolved to include proprietary asset development and the recent launch of Bio Valys Pharma (BVP), an autonomous pharmaceutical platform designed to market essential medicines. The company operates as an integrated partner, assisting clients with complex regulatory hurdles, bioequivalence risks, and market access strategies in Europe and the US.